Contact Us

Lyrica
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

Was suicide attempted?

Did loved one commit suicide?

What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

If patient did commit suicide, what was the method of suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?

Please describe any psychiatric conditions diagnosed before starting Lyrica:

Did Lyrica help the condition that it was prescribed for?

Please further describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Lyrica

Doctor Accused of Falsifying Drug Studies Pleads Guilty

Feb 23, 2010
| Parker Waichman LLP
Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health...

Pfizer Geodon Whistleblower Represented by Parker Waichman LLP

Sep 9, 2009
| Parker Waichman LLP
A whistleblower who was involved in last week's record breaking $2.3 billion Pfizer settlement was represented by the Great Neck, NY law firm of...

Pfizer's Illegal Promotion of Bextra and Other Drugs Results in Record Settlement, Guilty Plea

Sep 3, 2009
| Parker Waichman LLP
Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Company Inc., have agreed to pay a record-setting $2.3 billion to settle claims arising from...

Baystate Medical Center Subpoenaed Over Fake Drug Studies

Apr 8, 2009
| Parker Waichman LLP
The Baystate Medical Center has received a subpoena as part of a federal investigation into a doctor there who falsified 21 drug studies. ...

Researcher Faked Data for 21 Studies Involving Vioxx, Celebrex and Other Drugs

Mar 11, 2009
| Parker Waichman LLP
Medical journals have been asked to retract 21 studies that touted the benefits of Vioxx, Celebrex and other drugs.  According to The Wall...

Lyrica, Cymbalta Fibromyalgia Promotions Questioned

Feb 9, 2009
| Parker Waichman LLP
Two drug makers are spending a fortune to promote medications for a disease that some doctors say may not even exist.  According to the...

Epilepsy Drugs to Carry Suicide Warnings

Dec 17, 2008
| Parker Waichman LLP
Epilepsy drugs must now carry warnings about their suicide risks, the Food & Drug Administration (FDA) has announced.  The drugs subject to...

Epilepsy Drugs Targeted for Black Box Suicide Warning

Jul 8, 2008
| Parker Waichman LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...

New Suicide Warning for Epilepsy Drugs

Jun 12, 2008
| Parker Waichman LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior.  The...

Epilepsy Drugs to Get Suicide Warnings, FDA Confirms

Jun 6, 2008
| Parker Waichman LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today.  This past...

Page 1/2 [first] [prev] 1 2 [next] [last]